Arsanis, Inc. (ASNS)


Arsanis, Inc. (ASNS)

$3.11 USD

0.13 (-3.86%)

Updated Mar 13 7:48pm

Add ASNS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

ASNS Daily Price Range
ASNS 52-Week Price Range

ASNS Stock Chart More Charts


ASNS Price/Volume Stats

Current price $3.11
Prev. close $3.23
Day low $3.05
Day high $3.78
50-day MA $2.99
200-day MA $4.17
52-week high $28.69
52-week low $1.15
Volume 607,200
Avg. volume 164,537
Dividend yield N/A
Market Cap 45.54M

Arsanis, Inc. (ASNS) Company Bio


Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. Its lead product candidate is ASN100, a first-in-class mAb therapeutic in Phase II clinical development for the prevention of staphylococcus aureus pneumonia. The company’s preclinical pipeline comprises mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus. Arsanis, Inc. was founded in 2010 and is based in Waltham, Massachusetts.





ASNS News Stream


Event/Time News Detail
Loading, please wait...

ASNS Social Stream


Loading social stream, please wait...

View Full ASNS Social Stream

ASNS Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 75.71%
3-year N/A
5-year N/A
YTD 34.05%
2018 -81.82%
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.4587 seconds.